Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three?

J Psychiatr Pract. 2009 Sep;15(5):415-22. doi: 10.1097/01.pra.0000361282.95962.9f.

Abstract

A Case is presented of a 23-year-old woman with progressive onset of paranoid psychosis and catatonia, who was ultimately found to have both vitamin B12 deficiency and a family history of bipolar disorder. The patient was initially diagnosed with schizophrenia and treated with the antipsychotic medication ziprasidone. Her condition rapidly worsened to a state consistent with either neuroleptic malignant syndrome or malignant catatonia. Work-up then revealed vitamin B12 deficiency and a family history of bipolar disorder. Her symptoms improved rapidly but partially with benzodiazepines and electrocon-vulsive therapy, and completely with addition of valproic acid, vitamin B12 replacement, and re-introduction of antipsychotic medication in the form of olanzapine. The authors discuss the differential diagnosis of catatonia as reflecting a high likelihood of underlying mood disorder; the evaluation and management of malignant catatonia and malignant neuroleptic syndrome; and the role of vitamin B12 deficiency in precipitating psychotic symptoms. The case also illustrates the problems of diagnosing and managing a multifactorial disorder with psychiatric, general medical, and perhaps iatrogenic components.

Publication types

  • Case Reports

MeSH terms

  • Bipolar Disorder / complications*
  • Bipolar Disorder / diagnosis
  • Bipolar Disorder / therapy
  • Catatonia / complications*
  • Catatonia / diagnosis
  • Catatonia / therapy
  • Diagnosis, Differential
  • Female
  • Humans
  • Neuroleptic Malignant Syndrome / complications*
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / therapy
  • Schizophrenia, Paranoid / diagnosis
  • Vitamin B 12 Deficiency / complications*
  • Vitamin B 12 Deficiency / therapy
  • Young Adult